March 22, 2017
Kadmon Reports Upcoming Milestones and Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017
Kadmon Announces Approximately $23 Million Equity Financing
December 06, 2016
Kadmon Presents Encouraging Data on Tesevatinib in EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases and/or Leptomeningeal Metastases
View and download our company filings.
View our latest investor presentations, webcasts and events calendar.
We are committed to maintaining ongoing, open dialogue with the investor community. Explore financial news, investor events, press releases and contact information here.
Learn more about investing in our growth.
Receive press releases, SEC filings and more.
Subscribe to alerts
Kadmon Corporation, LLC
Copyright 2017. All Rights Reserved.